Pacific Biosciences Of California (PACB)
EBITDA Growth
-6.96%
Quarterly · Period ending:
PACB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.96%period ending
Latest reported-6.96%period ending
PACB Quarterly EBITDA YoY % (-61.96% → -6.96%)
Year-over-year change
High-resolution chart · PNG
PACB ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -6.9628% | |
| 88.8818% | |
| -306.0636% | |
| 23.384% | |
| 77.1204% | |
| 17.1404% | |
| 124.2982% | |
| 40.0455% | |
| -153.1759% | |
| 21.6354% | |
| 10.9125% | |
| 0.6667% | |
| 3.4355% | |
| -8.2779% | |
| -24.9876% | |
| 4.2443% | |
| -81.6157% | |
| 11.4745% | |
| -178.3981% | |
| -236.8082% | |
| -68.2473% | |
| -2,239.2555% | |
| 2,394.674% | |
| 17.3958% | |
| 3.3076% | |
| 114.2936% | |
| 110.9115% | |
| -14.5733% | |
| -6.919% | |
| -25.0229% | |
| -54.9105% | |
| -15.3509% | |
| 11.402% | |
| -8.0133% | |
| -6.9436% | |
| -25.0159% | |
| -32.9278% | |
| -13.8963% | |
| -21,593.6709% | |
| 19.953% | |
| -64.0595% | |
| 3.8165% | |
| 99.5349% | |
| -164.1441% | |
| 39.4608% | |
| -8.2002% | |
| -8.9137% | |
| 60.1323% | |
| 7.4275% | |
| 10.9344% | |
| 22.3638% | |
| 11.3432% | |
| 10.1527% | |
| 26.1466% | |
| 5.1742% | |
| 25.0857% | |
| 2.7355% | |
| 22.741% | |
| 39.7074% | |
| 28.6781% | |
| 32.3842% | |
| -14.6323% | |
| -33.9638% | |
| -61.9615% |